Website of the Tokyo Metropolitan Transfusion Therapy Study Group

医療・福祉 東京都 東京都福祉保健局

What is the Tokyo Transfusion Therapy Study Group?

The Tokyo Metropolitan Government, the Tokyo Red Cross Blood Center, the Tokyo Medical Association, the Kanto-Koshinetsu Branch of the Japanese Society of Transfusion and Cell Therapy, and medical institutions in Tokyo exchange information and opinions to promote safe and appropriate health care in Tokyo. It was established in September 2003 with the aim of promoting the use of various blood products and the blood business.
Since its inception, it has been held once a year.

Outline of the 21st Tokyo Transfusion Therapy Study Group (FY2022)

The 21st Tokyo Transfusion Therapy Study Group was held as follows.

1 date and time

Monday, November 28, 2020

2 places

Tokyo Metropolitan Government No. 1 Main Building 5th Floor Large Conference Hall

3 program (titles omitted)

Part 1

1 2022 Minister of Health, Labor and Welfare Commendation Certificate/Certificate of Appreciation Presentation Ceremony for Distinguished Blood Donors and Tokyo Governor Certificate of Appreciation Presentation Ceremony
2 Blood Donation Seminar -Current Status and Challenges of Blood Donation-
Masato Tanaka (Tokyo Red Cross Blood Center)

Part 2

1 Keynote Speech "Trends of New Blood Products as Transfusion Therapy for Massive Bleeding"
[Chairman] Shigeyoshi Makino (Tokyo Red Cross Blood Center)
[Lecturer] Shigeki Miyata (Japanese Red Cross Society Central Blood Research Institute)

2 Blood transfusion therapy Q&A
[Chairman] Jun Ando (Department of Cell Therapy and Transfusion, Juntendo University School of Medicine)
Miki Okuyama (Department of Blood Transfusion and Cell Therapy, Tokyo Metropolitan Komagome Hospital)
(1) “About task shift and sharing for clinical laboratory technologists”
[Lecturer] Makoto Okuda (Department of Blood Transfusion, Toho University Medical Center Omori Hospital)
(2) “Regarding the partial revision of the ``Guidelines for retrospective investigation of blood products, etc.''''
[Performer] Rieko Ametani (Tokyo Red Cross Blood Center)

3 Transfusion Therapy Symposium "Perioperative Transfusion Management"
[Chairman] Tomohiko Sato (Department of Blood Transfusion and Cell Therapy, Jikei University Hospital)
Asashi Tanaka (Department of Blood Transfusion, Tokyo Medical University Hachioji Medical Center)
(1) Overview Hiroshi Fujita (Department of Blood Transfusion, Tokyo Metropolitan Bokuto Hospital)
(2) "Perioperative Patient Blood Management - Focusing on preoperative anemia countermeasures -"
Toshiyuki Ikeda (Department of Blood Transfusion, University of Tokyo Hospital)
(3) "Nursing perioperative blood transfusion"
Emi Nakano (Department of Nursing, Tokyo Metropolitan Bokuto Hospital)
(4) "Hemostasis strategy in the perioperative period"
Kotaro Kida (Department of Anesthesiology, Jikei University School of Medicine)

Past Tokyo Transfusion Therapy Study Group Reports (16th to 20th)

20th (2021) Report

File download: Opens in a new window. Table of Contents, P3 (1 About the 20th Tokyo Society for Transfusion Therapy) (PDF: 386KB)

File download: Opens in a new window. P4-15 (2 Transfusion Therapy Q&A About new drugs that affect transfusion testing (anti-CD38 antibody, anti-CD47 antibody)) (PDF: 2,017KB)

File download: Opens in a new window. P16-18 (3 Transfusion therapy symposium "Influence of new coronavirus infection on transfusion therapy" overview) (PDF: 673KB)

File download: Opens in a new window. P19-23 (3 transfusion therapy symposium Convalescent plasma therapy 1) (PDF: 1,412KB)

File download: Opens in a new window. P24-28 (3 Transfusion therapy symposium Convalescent plasma therapy 2) (PDF: 1,672KB)

File download: Opens in a new window. P29-33 (3 Blood transfusion therapy symposium About blood transfusion therapy when using ECMO 1) (PDF: 1,363KB)

File download: Opens in a new window. P34-39 (3 Blood Transfusion Therapy Symposium About blood transfusion therapy when using ECMO 2) (PDF: 1,611KB)

File download: Opens in a new window. P40-43 (3 Symposium on Blood Transfusion Therapy: From the Viewpoint of Home Therapy 1) (PDF: 1,111KB)

File download: Opens in a new window. P44-47 (3 Symposium on Blood Transfusion Therapy: From the Viewpoint of Home Therapy 2) (PDF: 1,290KB)

File download: Opens in a new window. P48-53 (3 Transfusion Therapy Symposium From the standpoint of the blood center 1) (PDF: 1,451KB)

File download: Opens in a new window. P54-59 (3 Transfusion Therapy Symposium From the standpoint of the blood center 2) (PDF: 1,345KB)

File download: Opens in a new window. P60-66 (3 Transfusion Therapy Symposium Discussion) (PDF: 1,548KB)

19th (2020) Report

File download: Opens in a new window. Table of Contents, P3 (About the 19th Tokyo Society for Transfusion Therapy) (PDF: 172KB)

File download: Opens in a new window. P4-17 (1 Keynote Lecture Revision of "Guidelines for the Implementation of Blood Transfusion Therapy") (PDF: 1,630KB)

File download: Opens in a new window. P18-25 (2 blood transfusion therapy Q&A (1) about cryoprecipitate newly covered by insurance) (PDF: 1,565KB)

File download: Opens in a new window. P26-36 (About 3 transfusion therapy Q&A (2) HEV infection and HEV screening) (PDF: 1,304KB)

File download: Opens in a new window. P38-45 (4 case studies: About in-hospital blood transfusion round at Bokuto Hospital) (PDF: 1,278KB)

18th (2019) Report

File download: Opens in a new window. P1-10 (table of contents, opening remarks, award ceremony for meritorious blood donors, blood donation seminar) (PDF: 3,003KB)

File download: Opens in a new window. P11-29 (keynote speech about guidelines for proper use of blood products for cases of massive bleeding) (PDF: 6,392KB)

File download: Opens in a new window. P30-38 (Transfusion therapy Q&A1 CAR-T treatment covered by health insurance - Impact on blood transfusion work -) (PDF: 3,652KB)

File download: Opens in a new window. P39-48 (Transfusion therapy Q&A2 points of medical law revision (quality control)) (PDF: 3,111KB)

File download: Opens in a new window. P49-63 (Symposium 1 Current status and issues of transfusion therapy in home blood transfusion (1) Current status of home blood transfusion in Tokyo) (PDF: 4,102KB)

File download: Opens in a new window. P64-83 (Symposium 2 (2) Challenges in blood transfusion testing, (3) Actual efforts for home blood transfusion) (PDF: 5,872KB)

File download: Opens in a new window. P84-91 (Symposium 3 (4) Closing remarks from the perspective of a nurse) (PDF: 2,584KB)

17th (FY2018) Report

File download: Opens in a new window. P1-10 (table of contents, opening remarks, award ceremony for meritorious blood donors, blood donation seminar) (PDF: 2,997KB)

File download: Opens in a new window. P11-24 (Keynote lecture: Prevention and treatment of transfusion adverse events) (PDF: 5,641KB)

File download: Opens in a new window. P25-42 (Transfusion therapy Q&A Changes in autologous blood transfusion in medical fee revision in 2018) (PDF: 5,998KB)

File download: Opens in a new window. P43-61 (Symposium 1 Safety measures in blood transfusion (1) Prevention of blood transfusion accidents learned from case studies) (PDF: 6,488KB)

File download: Opens in a new window. P62-82 (Symposium 2 (2) Analysis procedure and post-processing of blood transfusion-related serious accidents (incompatible transfusion, etc.), (3) Blood transfusion education in hospital rounds, (4) Efforts to prevent misidentification of patients (PDF: 5,880KB)

File download: Opens in a new window. P83-89 (Symposium 3 Discussion, Closing Remarks) (PDF: 2,116KB)

16th (FY2017) Report

File download: Opens in a new window. P1-10 (table of contents, opening remarks, award ceremony for meritorious blood donors, blood donation seminar) (PDF: 2,640KB)

File download: Opens in a new window. P11-26 (Keynote speech: Key points in the revision of the "Guidelines for the Use of Blood Products") (PDF: 6,339KB)

File download: Opens in a new window. P27-36 (Transfusion therapy Q&A about hepatitis E due to blood transfusion (1)) (PDF: 3,836KB)

File download: Opens in a new window. P37-44 (Transfusion therapy Q&A about hepatitis E due to blood transfusion (2)) (PDF: 2,963KB)

File download: Opens in a new window. P45-67 (Transfusion therapy symposium 1 Team medical care for safe blood transfusion (1) From the perspective of doctors, (2) From the perspective of nurses) (PDF: 6,520KB)

File download: Opens in a new window. P68-87 (Transfusion therapy symposium 2 (3) From the standpoint of clinical laboratory technologists, (4) From the standpoint of the Japanese Society of Transfusion and Cell Therapy, discussion, closing remarks) (PDF: 6,718KB)

Adobe Acrobat Reader DC (formerly Adobe Reader) is required to open PDF format files.
If you do not have it, you can download it for free from Adobe.
Get Adobe Acrobat Reader DC (Opens in a new window.) Download Adobe Acrobat Reader DC

inquiry

This page is in charge of Health Policy Department Disease Control Division am.

Back to blog